Literature DB >> 23797844

Evidence that alpha-9 human papillomavirus infections are a major etiologic factor for oropharyngeal carcinoma in black South Africans.

Cherie Paquette, Mark F Evans, Shabnum S Meer, Vanitha Rajendran, Christine S-C Adamson, Kumarasen Cooper.   

Abstract

Human papillomavirus (HPV) infection, most commonly genotype 16 of the alpha-9 family, is implicated in the etiology of a subset of oropharyngeal squamous cell carcinomas (OPSC) worldwide. Data are scarce regarding OPSC in South Africans, and three prior studies suggest no significant etiologic role for HPV. We aimed to investigate for evidence of HPV etiology in OPSCs from black South Africans by polymerase chain reaction (PCR) methodologies with determination of HPV subtype by sequencing, in situ hybridization (ISH), and p16INK4a immunohistochemistry (IHC), as a surrogate marker for an HPV-driven tumor. It was hypothesized that HPV-driven tumors would be positive by PCR plus IHC and/or ISH whereas OPSCs with HPV background infections (HPV-passenger) would be positive by PCR alone. Formalin-fixed, paraffin embedded tissues from 51 OPSCs collected between 2005 and 2010 from 41 patients were analyzed for HPV by GP5?6? PCR (targeting the HPV L1 region), pU-1M/pU- 2R PCR (targeting the HPV E6/E7 region) and HPV-31 specific PCR (targeting the E5 region), chromogenic ISH, and p16INK4a IHC. All cases positive by PCR were subject to sequencing to determine HPV genotype. The patient mean age was 58.0 years and 88 % were male. Of the 51 evaluable tumors, 48 (94.1 %) were positive for HPV DNA by PCR: 25 (49.1 %) met criteria for an HPV-driven tumor, 23 (45.1 %) for HPV-passenger, and 3 (5.9 %) were HPV unrelated. Sequencing of the PCR-positive cases revealed the following genotypes: combined HPV-16 and 31 (41.7 %), HPV-31 (25.0 %), HPV-16 (22.9 %), combined HPV-16 and 18 (6.3 %), and a single case each of HPV 18 and HPV 33. Studies via ISH were negative in all cases. In accordance with worldwide trends but contrary to prior South African data, HPV likely plays an etiologic role in a significant subset (at least 49.1 %) of OPSC in black South Africans. We found that the alpha-9 HPV family, particularly HPV-16 and 31 either in combination or separately, to predominate in our sample tumors. The use of multiple PCR primers increased sensitivity of viral detection, and a HPV-31 specific primer confirmed the presence of this genotype in many samples. Further studies including HPV E6/E7 mRNA assays are needed to better elucidate the pathogenic role of HPV in black South African OPSCs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23797844      PMCID: PMC3824804          DOI: 10.1007/s12105-013-0453-0

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  54 in total

1.  Is the human papillomavirus a mutual aetiological agent in oral and cervical squamous cell carcinoma?

Authors:  T C Postma; W F Van Heerden
Journal:  Anticancer Res       Date:  2003 Jul-Aug       Impact factor: 2.480

2.  Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia.

Authors:  Mark F Evans; Sharon L Mount; Barbara G Beatty; Kumarasen Cooper
Journal:  Mod Pathol       Date:  2002-12       Impact factor: 7.842

3.  Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation.

Authors:  K Cooper; C S Herrington; J E Stickland; M F Evans; J O McGee
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

Review 4.  Human papillomavirus and head and neck cancer: a systematic review and meta-analysis.

Authors:  C G L Hobbs; J A C Sterne; M Bailey; R S Heyderman; M A Birchall; S J Thomas
Journal:  Clin Otolaryngol       Date:  2006-08       Impact factor: 2.597

Review 5.  Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review.

Authors:  Aimee R Kreimer; Gary M Clifford; Peter Boyle; Silvia Franceschi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

6.  Use of multiple PCR primer sets for optimal detection of human papillomavirus.

Authors:  F Karlsen; M Kalantari; A Jenkins; E Pettersen; G Kristensen; R Holm; B Johansson; B Hagmar
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

7.  Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancers.

Authors:  Elaine M Smith; Linda M Rubenstein; Thomas H Haugen; Eva Hamsikova; Lubomir P Turek
Journal:  Cancer Causes Control       Date:  2010-04-17       Impact factor: 2.506

Review 8.  Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?

Authors:  Erich M Sturgis; Paul M Cinciripini
Journal:  Cancer       Date:  2007-10-01       Impact factor: 6.860

9.  Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction.

Authors:  Y Fujinaga; M Shimada; K Okazawa; M Fukushima; I Kato; K Fujinaga
Journal:  J Gen Virol       Date:  1991-05       Impact factor: 3.891

Review 10.  Pitfalls in the epidemiologic classification of human papillomavirus types associated with cervical cancer using polymerase chain reaction: driver and passenger.

Authors:  T Matsukura; M Sugase
Journal:  Int J Gynecol Cancer       Date:  2008-02-01       Impact factor: 3.437

View more
  9 in total

Review 1.  Epidemiology of HPV Related Malignancies.

Authors:  Nicholas Scott-Wittenborn; Carole Fakhry
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

2.  Human papillomavirus in head and neck squamous cell carcinoma: A descriptive study of histologically confirmed cases at Kamuzu Central Hospital in Lilongwe, Malawi.

Authors:  Claire E Faggons; Charles E Mabedi; N George Liomba; William K Funkhouser; Fred Chimzimu; Coxcilly Kampani; Robert Krysiak; Nelson Msiska; Carol G Shores; Satish Gopal
Journal:  Malawi Med J       Date:  2017-06       Impact factor: 0.875

3.  Human Papillomavirus Prevalence in Oral and Oropharyngeal Rinse and Gargle Specimens of Dental Patients and of an HIV-Positive Cohort from Pretoria, South Africa.

Authors:  Neil H Wood; Koketso S Makua; Ramokone L Lebelo; Nina Redzic; Ina Benoy; Olivier M Vanderveken; Johannes Bogers
Journal:  Adv Virol       Date:  2020-08-26

4.  Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique.

Authors:  Jeffrey Blumberg; Leonel Monjane; Manju Prasad; Carla Carrilho; Benjamin L Judson
Journal:  Cancer Epidemiol       Date:  2015-11-18       Impact factor: 2.984

5.  Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria.

Authors:  Emmanuel A Oga; Lisa M Schumaker; Biodun Sulyman Alabi; Darlington Obaseki; Aniefon Umana; Ima-Abasi Bassey; Godwin Ebughe; Olabode Oluwole; Teniola Akeredolu; Sally N Adebamowo; Patrick Dakum; Kevin Cullen; Clement A Adebamowo
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

6.  Human papillomavirus in head and neck squamous cell carcinomas in a South African cohort.

Authors:  Tumelo R Sekee; Felicity J Burt; Dominique Goedhals; Jacqueline Goedhals; Yuri Munsamy; Riaz Y Seedat
Journal:  Papillomavirus Res       Date:  2018-11-01

7.  Tobacco use and oral sex practice among dental clinic attendees.

Authors:  Neil H Wood; Olalekan A Ayo-Yusuf; Tshepo S Gugushe; John-Paul Bogers
Journal:  PLoS One       Date:  2019-03-13       Impact factor: 3.240

8.  Oral Human Papillomavirus Infection and Head and Neck Squamous Cell Carcinoma in Rural Northwest Cameroon.

Authors:  Eleni M Rettig; Zhen Gooi; Richard Bardin; Mesele Bogale; Lisa Rooper; Everistus Acha; Wayne M Koch
Journal:  OTO Open       Date:  2019-01-04

9.  Oral and oropharyngeal high-risk HPV prevalence, HIV status, and risk behaviours in a cohort of South African men who have sex with men.

Authors:  Harshita B Mistry; Ramokone L Lebelo; Fulufhelo Matshonyonge; Maphoshane Nchabeleng; Matsontso Mathebula; John-Paul Bogers; Neil H Wood
Journal:  AIMS Public Health       Date:  2021-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.